Document Details
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company BiomX Inc. (Ness Ziona, Central)
Event Date 10/28/2019
Filing Date 11/1/2019

Abstract: 8-K filed by BiomX Inc. (PHGE) covering Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Changes in Registrant's Certifying Accountant; Changes in Control of Registrant; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Change in Shell Company Status; and Financial Statements and Exhibits.
Download

File Section(s)

  1. CURRENT REPORT
  2. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY, EFFECTIVE ON DECEMBER 11, 2018
  3. CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF THE COMPANY, EFFECTIVE ON OCTOBER 28, 2019
  4. AMENDED AND RESTATED BYLAWS OF THE COMPANY
  5. REGISTRATION RIGHTS AGREEMENT
  6. ESCROW AGREEMENT DATED OCTOBER 28, 2019
  7. VOTING AGREEMENT
  8. FORM OF INDEMNIFICATION AGREEMENT WITH EACH DIRECTOR AND OFFICER
  9. RESEARCH AND LICENSE AGREEMENT, DATED JUNE 22, 2015, BETWEEN BIOMX LTD. AND YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITE
  10. EXCLUSIVE PATENT LICENSE AGREEMENT DATED, APRIL 25, 2017, BETWEEN BIOMX LTD. AND THE MASSACHUSETTS INSTITUTE OF TECHNOLO
  11. EXCLUSIVE PATENT LICENSE AGREEMENT, DATED DECEMBER 15, 2017, AMONG BIOMX LTD., KEIO UNIVERSITY AND JSR CORPORATION, AS A
  12. EXCLUSIVE PATENT LICENSE AGREEMENT, DATED APRIL 22, 2019, AMONG BIOMX LTD., KEIO UNIVERSITY AND JSR CORPORATION
  13. SHARE PURCHASE AGREEMENT, DATED NOVEMBER 19, 2017, AMONG BIOMX LTD., RONDINX LTD. AND GUY HARMELIN, AS THE SHAREHOLDERS'
  14. CHARDAN HEALTHCARE ACQUISITION CORP. 2019 EQUITY INCENTIVE PLAN
  15. WAIVER AGREEMENT DATED OCTOBER 28, 2019
  16. PURCHASE AGREEMENT, DATED OCTOBER 28, 2019, BETWEEN CORNIX LLC AND CHARDAN HEALTHCARE ACQUISITION CORP
  17. LETTER FROM MARCUM LLP
  18. RESIGNATION OF GEORGE KAUFMAN
  19. RESIGNATION OF MICHAEL RICE
  20. RESIGNATION OF RICHARD GIROUX
  21. RESIGNATION OF MATTHEW ROSSEN
  22. RESIGNATION OF ERIC KUSSELUK, M.D.
  23. SUBSIDIARIES OF REGISTRANT
  24. PRESS RELEASE DATED OCTOBER 28, 2019
  25. AUDITED FINANCIAL STATEMENTS OF BIOMX LTD.
  26. PRO FORMA FINANCIAL STATEMENTS

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.

Arrow